KURK—a safer way to manage pain and inflammation
We’re proud to see this question—one at the heart of our mission—spotlighted in the Australian Financial Review.
In a feature exploring the origins of KURK and whether natural compounds like curcumin could provide a safer alternative to opioid painkillers, AFR highlights a growing shift in chronic pain management: away from long-term pharmaceuticals and toward clinically validated plant-based solutions.
At KURK, we’re part of that shift. Our science-led approach to curcumin is designed to address inflammation at the root—with better absorption, measurable results, and no compromise on safety.
Unlocking the full power of curcumin
While curcumin’s anti-inflammatory potential has been studied for decades, most formulations don’t deliver enough of it to make a meaningful difference.
That’s where KURK comes in.
Our plant-based solution uses micelle encapsulation technology to dramatically enhance curcumin’s bioavailability—by up to 1000x compared to standard turmeric. That means faster absorption, better targeting, and more consistent results. No black pepper. No guesswork. Just effective, high-impact delivery designed for real life.
Why we created KURK
KURK was born out of a personal journey. Our co-founder and CEO, Trent Scanlen, turned to curcumin during cancer recovery—not as a miracle cure, but as a way to support his body through inflammation, fatigue, and long-term healing.
He teamed up with Dr. Harry Weisinger, a medical doctor and former head of biosciences at Deakin University, to create a curcumin formulation that wasn’t just convenient—but truly effective. The result was KURK: a clean, bioavailable, data-backed inflammation solution built for daily use.
Not just hope—measurable change
Early results from our latest clinical study are in—and the impact is significant. The full study will be published next month, but here’s a first look at what we’re seeing:
-
100% of users experienced at least a 20% reduction in joint pain
-
87.5% saw a 50%+ reduction
-
Over two-thirds reached a 70%+ improvement
-
Most felt the difference within 16 days
-
No adverse effects reported
What’s especially powerful? These changes happened even without major shifts in systemic inflammation markers—suggesting KURK may work directly at the site of inflammation, such as in the joints, rather than relying on a systemic response.
For people seeking alternatives to long-term NSAIDs or stronger pain relief, KURK offers a safer, non-addictive option backed by real-world data.
So… is KURK the answer?
We wouldn’t claim it’s a silver bullet for all inflammatory conditions—but the evidence is growing. With high-bioavailability delivery and proper dosing, curcumin is becoming one of the most promising natural tools we have for managing inflammation safely and effectively.
At KURK, we believe people deserve better options. Backed by data. Reinforced with results.
Curious to learn more?
Explore the full AFR feature that spotlighted KURK’s approach. Read the article – subscription required
